Does treatment with rosiglitazone result in improved pancreatic beta-cell function as compared to glimepiride in metformin treated diabetes type 2 patients?
Suspended
- Conditions
- Type 2 diabetes.Type 2 diabetes is a heterogeneous disorder involving varying levels of insulin insensitivity and impaired islet beta-cell function.
- Registration Number
- NL-OMON27919
- Lead Sponsor
- Academic Medical Center - Amsterdam
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- Not specified
- Target Recruitment
- 22
Inclusion Criteria
1. Informed consent form signed;
2. Type 2 diabetes patients, accoring to WHO criteria;
Exclusion Criteria
1. Established coronary heart disease;
2. Previous use of a thiazolidinedione.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The peak insulin concentrations during the hyperglycaemic clamp protocol.
- Secondary Outcome Measures
Name Time Method